Capacities of the current angiotensin-converting enzyme inhibitor zofenopril in clinical practice: cardioprotective, anti-ischemic, and antiatherogenic effects

Capacities of the current angiotensin-converting enzyme inhibitor zofenopril in clinical practice: cardioprotective, anti-ischemic, and antiatherogenic effects

The given review discusses the use of angiotensin-converting enzyme (ACE) inhibitors in patients with cardiovascular diseases, including those with prior acute myocardial infarction. The paper places particular emphasis on the currently available ACE inhibitor zofenopril. It discusses its special ph...

Full description

Bibliographic Details
Main Author: M. G Bubnova
Format: Article
Language:English
Published: Concilium Medicum 2013-03-01
Series:КардиоСоматика
Subjects:
myocardial infarction
zofenafil
cardioprotection
Online Access:https://cardiosomatics.orscience.ru/2221-7185/article/view/45050
id doaj-56f05b2d949c456d989ced66d7c2a304
record_format Article
spelling doaj-56f05b2d949c456d989ced66d7c2a3042021-04-02T17:52:24ZengConcilium MedicumКардиоСоматика2221-71852658-57072013-03-0141627140716Capacities of the current angiotensin-converting enzyme inhibitor zofenopril in clinical practice: cardioprotective, anti-ischemic, and antiatherogenic effectsM. G Bubnova0State Research Center for Preventive Medicine, Ministry of Health of the Russian FederationThe given review discusses the use of angiotensin-converting enzyme (ACE) inhibitors in patients with cardiovascular diseases, including those with prior acute myocardial infarction. The paper places particular emphasis on the currently available ACE inhibitor zofenopril. It discusses its special pharmacological properties and considers its additional effects associated with cardioprotective, anti-ischemic, antiatherogenic effects. The review provides a rationale for the clinical efficacy of zofenopril and a possibility for its wider clinical application.https://cardiosomatics.orscience.ru/2221-7185/article/view/45050myocardial infarctionzofenafilcardioprotection
collection DOAJ
language English
format Article
sources DOAJ
author M. G Bubnova
spellingShingle M. G Bubnova
Capacities of the current angiotensin-converting enzyme inhibitor zofenopril in clinical practice: cardioprotective, anti-ischemic, and antiatherogenic effects
КардиоСоматика
myocardial infarction
zofenafil
cardioprotection
author_facet M. G Bubnova
author_sort M. G Bubnova
title Capacities of the current angiotensin-converting enzyme inhibitor zofenopril in clinical practice: cardioprotective, anti-ischemic, and antiatherogenic effects
title_short Capacities of the current angiotensin-converting enzyme inhibitor zofenopril in clinical practice: cardioprotective, anti-ischemic, and antiatherogenic effects
title_full Capacities of the current angiotensin-converting enzyme inhibitor zofenopril in clinical practice: cardioprotective, anti-ischemic, and antiatherogenic effects
title_fullStr Capacities of the current angiotensin-converting enzyme inhibitor zofenopril in clinical practice: cardioprotective, anti-ischemic, and antiatherogenic effects
title_full_unstemmed Capacities of the current angiotensin-converting enzyme inhibitor zofenopril in clinical practice: cardioprotective, anti-ischemic, and antiatherogenic effects
title_sort capacities of the current angiotensin-converting enzyme inhibitor zofenopril in clinical practice: cardioprotective, anti-ischemic, and antiatherogenic effects
publisher Concilium Medicum
series КардиоСоматика
issn 2221-7185
2658-5707
publishDate 2013-03-01
description The given review discusses the use of angiotensin-converting enzyme (ACE) inhibitors in patients with cardiovascular diseases, including those with prior acute myocardial infarction. The paper places particular emphasis on the currently available ACE inhibitor zofenopril. It discusses its special pharmacological properties and considers its additional effects associated with cardioprotective, anti-ischemic, antiatherogenic effects. The review provides a rationale for the clinical efficacy of zofenopril and a possibility for its wider clinical application.
topic myocardial infarction
zofenafil
cardioprotection
url https://cardiosomatics.orscience.ru/2221-7185/article/view/45050
work_keys_str_mv AT mgbubnova capacitiesofthecurrentangiotensinconvertingenzymeinhibitorzofenoprilinclinicalpracticecardioprotectiveantiischemicandantiatherogeniceffects
_version_ 1721552985389006848

Similar Items